Zobrazeno 1 - 10
of 420
pro vyhledávání: '"Masahiko AOKI"'
Autor:
Ryo Saga, PhD, Yusuke Matsuya, PhD, Hideki Obara, PhD, Fumio Komai, MS, Hironori Yoshino, PhD, Masahiko Aoki, PhD, MD, Yoichiro Hosokawa, PhD, DDS
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 4, Pp 101437- (2024)
The generality of a model for predicting tumor control probability from in vitro clonogenic survival considering of cancer stem-like cells, the so-called integrated microdosimetric-kinetic model, is presented by comparing the model to public data on
Externí odkaz:
https://doaj.org/article/8c640287a98b4c858e66c57fdd96d77b
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 9, Pp 6986-6994 (2023)
The output constancy of the accelerator used for boron neutron capture therapy (BNCT) is essential to ensuring anti-tumor efficacy and safety. BNCT as currently practiced requires a wide variety of beam quality assessments to ensure that RBE dose err
Externí odkaz:
https://doaj.org/article/fbbf398b3be04a52ac3a7a07bb653ee2
Autor:
Yosui Nojima, Masahiko Aoki, Suyong Re, Hidekazu Hirano, Yuichi Abe, Ryohei Narumi, Satoshi Muraoka, Hirokazu Shoji, Kazufumi Honda, Takeshi Tomonaga, Kenji Mizuguchi, Narikazu Boku, Jun Adachi
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 21, Iss , Pp 2172-2187 (2023)
Apatinib is known to be a highly selective vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with anti-angiogenic and anti-tumor properties. In a phase III study, the objective response rate to apatinib was low. It remains unclear why
Externí odkaz:
https://doaj.org/article/96f2d6f634004bf692af38e6773e75d9
Autor:
Hiroki Yamamoto, Ami Sasaki, Mizuki Osaka, Koji Shirakawa, Morio Seino, Takaaki Matsuhashi, Yasuyuki Takahashi, Tsutomu Zeniya, Shota Hosokawa, Masataka Narita, Masahiko Aoki
Publikováno v:
Radiation, Vol 2, Iss 2, Pp 168-176 (2022)
The step-and-shoot (SS) mode and continuous mode are currently used for single-photon emission computed tomography (SPECT) scan mode, and a new scan mode that combines both modes, step-and-shoot plus continuous (SSC) mode, was developed. It is expect
Externí odkaz:
https://doaj.org/article/7d3afc98d0db4043bb19e839503bd696
Autor:
Hidekazu Hirano, Yuichi Abe, Yosui Nojima, Masahiko Aoki, Hirokazu Shoji, Junko Isoyama, Kazufumi Honda, Narikazu Boku, Kenji Mizuguchi, Takeshi Tomonaga, Jun Adachi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Phosphoproteomic analysis expands our understanding of cancer biology. However, the feasibility of phosphoproteomic analysis using endoscopically collected tumor samples, especially with regards to dynamic changes upon drug treatment, remain
Externí odkaz:
https://doaj.org/article/23b1b93b6df84053b303f6da1b5e6546
Autor:
Takaya Yamamoto, Yuzuru Niibe, Masahiko Aoki, Hiroshi Onishi, Kazunari Yamada, Takashi Shintani, Hideomi Yamashita, Mitsuru Kobayashi, Ryoong‐Jin Oh, Keiichi Jingu
Publikováno v:
Precision Radiation Oncology, Vol 5, Iss 2, Pp 84-92 (2021)
Abstract Objective This study aimed to analyze the early mortality rates and patterns of relapse after stereotactic body radiotherapy (SBRT) as an initial metastasis‐directed therapy. Methods Patients with pulmonary oligometastases initially treate
Externí odkaz:
https://doaj.org/article/2274e35d8b40464d930655e6d9c67b2b
Autor:
Takaya Yamamoto, Yuzuru Niibe, Masahiko Aoki, Takashi Shintani, Kazunari Yamada, Mitsuru Kobayashi, Hideomi Yamashita, Masatoki Ozaki, Yoshihiko Manabe, Hiroshi Onishi, Katsuya Yahara, Atsushi Nishikawa, Kuniaki Katsui, Ryoong-Jin Oh, Atsuro Terahara, Keiichi Jingu
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Successful local therapy for oligometastases may lead to longer survival. The purpose of this multicentre retrospective study was to investigate factors affecting the local control (LC) of pulmonary oligometastases treated by ster
Externí odkaz:
https://doaj.org/article/5ec43898173343a1956fe60ec1b18540
Autor:
Ken Masuda, Hirokazu Shoji, Kengo Nagashima, Shun Yamamoto, Masashi Ishikawa, Hiroshi Imazeki, Masahiko Aoki, Takahiro Miyamoto, Hidekazu Hirano, Yoshitaka Honma, Satoru Iwasa, Natsuko Okita, Atsuo Takashima, Ken Kato, Narikazu Boku
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Recent studies have shown that immune-related adverse events (irAEs) caused by immune checkpoint inhibitors were associated with clinical benefit in patients with melanoma or lung cancer. In advanced gastric cancer (AGC) patients,
Externí odkaz:
https://doaj.org/article/7a4e76f42936477f8c32d0e12dbecb95
Autor:
Masashi Ishikawa, Atsuo Takashima, Yusuke Nagata, Ryoichi Sawada, Masahiko Aoki, Hiroshi Imazeki, Hidekazu Hirano, Hirokazu Shoji, Yoshitaka Honma, Satoru Iwasa, Natsuko Okita, Ken Kato, Masayuki Saruta, Narikazu Boku
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0257551 (2021)
BackgroundIn clinical practice, the same chemotherapeutic agents are occasionally reused (re-challenge) after failure of all available standard chemotherapy options for metastatic colorectal cancer (mCRC). However, the benefits of re-challenge chemot
Externí odkaz:
https://doaj.org/article/80f72f9eb44243b8941b7eac292aa720
Autor:
Katsumi Hirose, Mariko Sato, Yoshiomi Hatayama, Hideo Kawaguchi, Fumio Komai, Makoto Sohma, Hideki Obara, Masashi Suzuki, Mitsuki Tanaka, Ichitaro Fujioka, Koji Ichise, Yoshihiro Takai, Masahiko Aoki
Publikováno v:
Radiation Oncology, Vol 13, Iss 1, Pp 1-14 (2018)
Abstract Background The purpose of this study was to evaluate the impact of markerless on-board kilovoltage (kV) cone-beam computed tomography (CBCT)-based positioning uncertainty on determination of the planning target volume (PTV) margin by compari
Externí odkaz:
https://doaj.org/article/9d974595f74240cf989b620b1be07d32